Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. C. Raimondi
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Clinical Cancer Research
Cancer Research
Oncology
Molecular Emergence of Acute Myeloid Leukemia During Treatment for Acute Lymphoblastic Leukemia
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Antibody-Based Therapy of Acute Myeloid Leukemia With Gemtuzumab Ozogamicin
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Gemtuzumab Ozogamicin in Children With Relapsed or Refractory Acute Myeloid Leukemia: A Report of Berlin-Frankfurt-Münster Study Group
Haematologica
Hematology
DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia
Haematologica
Hematology
Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia
Scientific Reports
Multidisciplinary
Predictors and Short-Term Outcomes of Hyperleukocytosis in Children With Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Haematologica
Hematology
The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia
Oncologist
Cancer Research
Medicine
Oncology
High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902
Leukemia Research
Cancer Research
Oncology
Hematology
AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
